Projected Income Statement: Vext Science, Inc.

Forecast Balance Sheet: Vext Science, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 7.64 32.2 29.9 34.9 - -13.9 0.1 12.1
Change - 321.47% -7.14% 16.72% - - 100.72% 12,000%
Announcement Date 4/20/22 3/22/23 5/10/24 3/31/25 4/29/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Vext Science, Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 18.78 8.86 2.737 1.465 - 1.374 1.355 1.48
Change - -52.83% -69.11% -46.46% - - -1.38% 9.23%
Free Cash Flow (FCF) 1 -7.102 -2.938 1.688 1.823 8.145 9.409 17.75 19.63
Change - 58.64% 157.45% 8.04% 346.73% 15.52% 88.6% 10.59%
Announcement Date 4/20/22 3/22/23 5/10/24 3/31/25 4/29/26 - - -
1CAD in Million
Estimates

Forecast Financial Ratios: Vext Science, Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

         
EBITDA Margin (%) - 35.96% 42.69% 15.88% 25.43% - 29% 28.72% 29.73%
EBIT Margin (%) - - - -22.53% -31.06% - 0.37% 5.95% -
EBT Margin (%) - - - - - -29.62% -4.28% 4.91% -2.57%
Net margin (%) - - - - - -35.03% -4.28% 3.44% -2.16%
FCF margin (%) - -19.07% -8.3% 4.85% 5.06% 15.86% 17.49% 25.74% 26.52%
FCF / Net Income (%) - - - - - -45.27% -409.09% 748.6% -1,226.59%

Profitability

         
ROA 4.29% 7.17% 5.67% -3.62% -5.04% -3.37% - - -
ROE 6.86% 10.42% 16.63% 5.27% -26.28% -27.96% - - -

Financial Health

         
Leverage (Debt/EBITDA) - 0.57x 2.13x 5.4x 3.81x - - 0.01x 0.55x
Debt / Free cash flow - -1.08x -10.97x 17.7x 19.14x - - 0.01x 0.62x

Capital Intensity

         
CAPEX / Current Assets (%) - 50.43% 25.02% 7.86% 4.07% - 2.55% 1.97% 2%
CAPEX / EBITDA (%) - 140.24% 58.61% 49.52% 16.01% - 8.81% 6.84% 6.73%
CAPEX / FCF (%) - -264.47% -301.62% 162.18% 80.37% - 14.6% 7.64% 7.54%

Items per share

         
Cash flow per share 1 - 0.1008 0.0583 0.0367 0.0197 - - - -
Change - - -42.2% -37.04% -46.35% - - - -
Dividend per Share 1 - - - - - - - - -
Change - - - - - - - - -
Book Value Per Share 1 - - - - - - - - -
Change - - - - - - - - -
EPS 1 - - - 0.041 -0.115 -0.0958 -0.014 0.014 -0.014
Change - - - - -380.53% 16.71% 85.38% 200% -200%
Nbr of stocks (in thousands) - 136,713 148,963 217,484 247,443 251,034 247,684 247,684 247,684
Announcement Date - 4/20/22 3/22/23 5/10/24 3/31/25 4/29/26 - - -
1CAD
Estimates
2026 *2027 *
P/E -17.5x 17.5x
PBR - -
EV / Sales 0.54x 0.63x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.2450CAD
Average target price
0.9500CAD
Spread / Average Target
+287.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VEXT Stock
  4. VV5 Stock
  5. Financials Vext Science, Inc.